Skip to main navigation Skip to search Skip to main content

Drug-protein binding during continuous ambulatory peritoneal dialysis

  • SUNY Buffalo

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

This study of drug-protein binding in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) measured the serum and dialysate binding of cefamandole - an acidic, cephalosporin antibiotic. Ten CAPD patients, five with and five without peritonitis received a 1.0 g intraperitoneal dose of cefamandole; serum and dialysate was sampled at 4, 10, and 24 h after drug administration. Binding also was studied in serum obtained from five chronic hemodialysis patients and five normal volunteers. Equilibrium dialysis was used to determine protein binding and high performance liquid chromatography to measure cefamandole. Mean fraction unbound (f(u)) serum values for CAPD patients were 0.35 ± 0.04 (noninfected) and 0.37 ± 0.14 (peritonitis). In comparison, the f(u) values in hemodialysis patients were 0.41 ± 0.19 and 0.15 ± 0.02 in normal volunteers. Greater than 90% of cefamandole in dialysate was unbound suggesting that antibiotics, which cross the peritoneal membrane, are present in the free, microbiologically active form.

Original languageEnglish
Pages (from-to)144-147
Number of pages4
JournalPeritoneal Dialysis Bulletin
Volume6
Issue number3
DOIs
StatePublished - 1986

Fingerprint

Dive into the research topics of 'Drug-protein binding during continuous ambulatory peritoneal dialysis'. Together they form a unique fingerprint.

Cite this